Christina Ackermann
CIK 1681871 · Please see remarks · last filed 2025-10-08
Christina Ackermann is a Please see remarks who has filed 46 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for OCS, was dated Oct 9, 2025. Across all open-market trades the lifetime net is −$4.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions. 31 SEC filings were submitted jointly with Bausch Health Companies Inc. 2 Form 144 notices of planned sales are also on file; the latest, for OCS on Oct 9, 2025, lists the filer as a director.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BHC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
400 SOMERSET CORPORATE BLVD.
BRIDGEWATER, NJ 08807
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) Delisted | Director | 0 | $106.91 | $0 | -$163.0K | 7 | 2025-10-08 |
| CALC | Director | 286 | $1.20 | $343 | $0 | 1 | 2023-03-27 |
| BLCO | Please see remarks | 146,677 | $20.73 | $3.04M | $0 | 3 | 2023-03-03 |
| CalciMedica, Inc. (GRAY) Delisted | Director | — | $5.50 | — | $0 | 3 | 2022-06-03 |
| BHC | EVP AND GENERAL COUNSEL | 162,240 | $8.58 | $1.39M | -$4.45M | 23 | 2022-03-11 |
Recent Filings
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-09 | OCS | Notice (144) Director · Planned Oct 9, 2025 · 10b5-1 plan No sale on file |
−7,460 | -$148.2K | EDGAR |
| 2025-10-08 | Verona Pharma plc (VRNA) Delisted | Mixed | −64,072 | $0 | EDGAR |
| 2025-08-05 | Verona Pharma plc (VRNA) Delisted | Mixed | +22,192 | -$23.8K | EDGAR |
| 2025-05-16 | Verona Pharma plc (VRNA) Delisted | Mixed10b5-1 Plan adopted Feb 12, 2025 |
— | -$260.2K | EDGAR |
| 2025-05-14 | Verona Pharma plc | Notice (144) Director · Planned May 14, 2025 · 10b5-1 plan No sale on file |
−5,000 | -$337.9K | EDGAR |
| 2025-04-29 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-11-07 | Verona Pharma plc (VRNA) Delisted | Buy (P) | +41,880 | $198.4K | EDGAR |
| 2024-04-30 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-09-05 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-27 | CALC | Disp (D) | +1,429 | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).